AI-generated summary
The authors compared a 577 nm pro-yellow laser added to topical sunscreen and hydroquinone with the same topical treatment alone in a split-face design in 82 patients with melasma. Both sides improved at 3 months, and at 6 months the laser-treated side had a significantly lower Melasma Area and Severity Index than the untreated side.
- Participants
- 82
- Who or what was studied
- Patients with melasma
- Wavelengths
- 577 nm
- Limits stated in the abstract
- The abstract does not describe a randomized design or blinding, and it reports only a single laser pass per session with three monthly sessions, so generalizability and long-term durability beyond 6 months are unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 577 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.